Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Oral salmon calcitonin shows potential as antidiabetic therapy in vivo

Oct. 31, 2012

Takeda submits Japanese NDA for cetilistat

Oct. 31, 2012

E.U. approval for linagliptin as add-on therapy in type 2 diabetes

Oct. 30, 2012

ViaCyte receives grant to continue development of diabetes therapy

Oct. 30, 2012

FDA turns down request for appeal on NDA for vaginal gel in preterm birth

Oct. 29, 2012

New GPR119 receptor agonists disclosed by Arena Pharmaceuticals

Oct. 29, 2012

Chugai enters Japanese license agreement for CSG-452

Oct. 29, 2012

FDA accepts NDA filing for controlled-release misoprostol vaginal insert

Oct. 26, 2012

Prodrug formulated to deliver simvastatin to skeletal tissue

Oct. 26, 2012

SJT Molecular Research divulges new agents for metabolic syndrome

Oct. 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...